Impact on Hemoglobin of Starting Combination Antiretroviral Therapy With or Without Zidovudine in Anemic HIV-Infected Patients
- 1 June 2008
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 48 (2) , 163-168
Abstract
Objective: To evaluate, among anemic patients with HIV, the impact on hemoglobin (Hb) of initiating zidovudine (AZT)-containing and non-AZT-containing combination antiretroviral therapy (cART). Methods: We used medical records data collected in 11 US cities from 1998 to 2004. Baseline anemia was described as mild (10 < Hb ≤ 12 [women] or 14 [men] g/dL), moderate (8 < Hb ≤ 10 g/dL), or severe (Hb ≤ 8 g/dL). Improvement of anemia was a ≥1-g/dL increase in Hb, with a decrease in categoric severity. We excluded patients previously treated with erythropoietin or transfusion, and used Cox proportional hazards regression to describe factors associated with hazard of improvement of anemia. Results: For 1620 patients initiating cART, more than half (54%) of patients had improvement of anemia. Time to improvement of anemia was longer for those initiating AZT-containing regimens and blacks and was shorter for those with moderate and severe anemia or CD4 counts <200 cells/μL. Conclusions: Most anemic patients initiating cART (with or without AZT) had increases in Hb-especially those with more severe anemia or immunosuppression. Initiation of AZT-containing cART may be considered, even for patients with preexisting anemia; however, improvement of anemia may be delayed for black patients and for patients with mild disease.Keywords
This publication has 20 references indexed in Scilit:
- Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human immunodeficiency virus-infected patients: findings of the Anemia Prevalence StudyCurrent Medical Research and Opinion, 2007
- Hematologic reference values for African American children and adolescentsAmerican Journal of Hematology, 2006
- Hematologic differences between African-Americans and whites: the roles of iron deficiency and α-thalassemia on hemoglobin levels and mean corpuscular volumeBlood, 2005
- Population-Based Hematologic and Immunologic Reference Values for a Healthy Ugandan PopulationClinical and Vaccine Immunology, 2004
- Anemia and Survival in Human Immunodeficiency VirusClinical Infectious Diseases, 2003
- Associations of Anemia, Treatments for Anemia, and Survival in Patients with Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2002
- Prevalence and Cumulative Incidence of and Risk Factors for Anemia in a Multicenter Cohort Study of Human Immunodeficiency Virus–Infected and –Uninfected WomenClinical Infectious Diseases, 2002
- Human Immunodeficiency Virus Infection, Anemia, and SurvivalClinical Infectious Diseases, 1999
- Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across EuropeAIDS, 1999
- Anemia is prevalent in an urban, African-American adolescent populationArchives of Family Medicine, 1995